The Neurofibromatosis-associated Tumor Biobank

NCT03359304 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-12-02

No results posted yet for this study

Summary

Neurofibromatosis-associated Tumor is very rare bone tumor. The investigator set up the biobank to ensure every patient has the chance to participate in future research

Conditions

  • Neurofibromatoses

Sponsors & Collaborators

  • Ren tingting

    lead OTHER

Principal Investigators

  • Tingting Ren, phD · Peking University People's Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2023-03-01
Completion
2028-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03359304 on ClinicalTrials.gov